Nucleai’s Post

Discover the transformative role of AI-driven spatial biomarkers in precision oncology in {{linkedin_mention(urn:li:organization:5167866|Inside Precision Medicine)}}'s latest article, 'Aiming AI at Cancer-Related Biomarkers,' featuring our very own Dr. {{linkedin_mention(urn:li:person:EnqXQZJA7j|Ken Bloom)}}. Learn how these advancements are reshaping the next generation of cancer treatments. Read the full article written by {{linkedin_mention(urn:li:person:EwxSQuYWZa|Mike May)}} : https://lnkd.in/gfhiV3e2 #spatialbiology #digitalpathology #spatialbiomarkers #biomarkers #Dx #precisiononcology

𝗛𝗼𝘄 𝗰𝗮𝗻 𝗔𝗜 𝗮𝗻𝗱 𝗿𝗲𝗮𝗹-𝘄𝗼𝗿𝗹𝗱 𝗲𝘃𝗶𝗱𝗲𝗻𝗰𝗲 𝗰𝗼𝗻𝘁𝗿𝗶𝗯𝘂𝘁𝗲 𝘁𝗼 𝗲𝗹𝗲𝘃𝗮𝘁𝗶𝗻𝗴 𝗰𝗮𝗻𝗰𝗲𝗿 𝗰𝗮𝗿𝗲 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀 𝘄𝗵𝗶𝗹𝗲 𝗺𝗶𝘁𝗶𝗴𝗮𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗼𝘃𝗲𝗿𝗮𝗹𝗹 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗰𝗼𝘀𝘁𝘀?   Uncover groundbreaking insights in the dynamic session “Frontiers of Real-World Evidence and AI in #cancercare,” facilitated by Yuwei Z. at the groundbreaking OncoVision 2024: the global metaverse conference on precision oncology. Explore how you can integrate such insightful sessions and research studies to make informed decisions for the overall growth of your business by emailing us at contact@iebrain.com. To know more, visit us: www.iebrain.com. #ebrainOncoVision #oncology #immunotherapy #generativeai #nanomedicine #precisiononcology #futureproofingbusinesses

💡Case Study: Multi-Modal Biomarker Discovery 💡 View Now: https://bit.ly/3UoFFHx As the only company that can integrate multi-omics with imaging data, we enable diagnostics companies to generate new insights for novel biomarker discovery. Explore how Sonrai's multi-modal approach helped develop an early-stage breast cancer diagnostic test. #diagnostics #AI #precisionmedicine #multimodaldata #imaging #multiomics #Sonrai #SonraiAnalytics #SonraiDiscovery

Visualizing co-localization of tumor cells and drugs in high-resolution is difficult with current 2D in vivo imaging techniques. Discover how Cryo-Fluorescence Tomography (CFT) is taking preclinical imaging to new heights! Download webinar to see what you're missing: https://bit.ly/3SkzP7A #fluorescence #preclinicalresearch #preclinicalimaging #oncology #immunotherapy

🔬 Insights from ASCO 2024! Dr Roger Sun from Institut Gustave Roussy presents a study on an AI-powered tool for assessing tumour-infiltrating CD8 T cells in NSCLC. This non-invasive approach enables virtual biopsies to map tumour microenvironments, identifying lesions most likely to progress and guiding targeted treatments. Discover the potential for AI in precision oncology. Discover these updates.👇 For all ASCO 2024 videos, find the link in the comments! #MediMix #ASCO2024 #LungCancer #OncologyInnovation #NSCLC #Radiomics #AI

Oral #oncology applications for ultrasound and photoacoustic imaging, presented by Dr. Mukund Seshadri. Learn about the translational possibilities of these imaging technologies in this upcoming webinar with FUJIFILM VisualSonics, Inc. Register here 👇 https://lnkd.in/gJrwWSvk Key topics include: ☑️ Development of ultrasound (US) and US-based methods including photoacoustic imaging (PAI) for clinical application in oral oncology ☑️ Evaluating PAI prognostic utility as a biomarker of tumor and normal tissue response to standard of care chemotherapy, radiation therapy and targeted therapy ☑️ Translating preclinical observations and further evaluating the performance of US-PAI for head and neck cancer patients #Imaging #Preclinical #Ultrasound

A New Era in Oncology: Cancer engineering! This emerging subfield of biomedical engineering integrates innovative approaches to tackle the complexities of cancer. From advanced imaging and nanotechnologies to genetic, cell, and tissue engineering hashtag #CancerResearch #BiomedicalEngineering #CancerEngineering #Innovation #Healthcare #Oncology #Nanotechnology #MedicalAdvancements #InterdisciplinaryScience #FutureOfMedicine

Adaptive Radiotherapy (ART) is at the forefront of innovation in cancer care, offering the potential for precise and responsive treatment solutions. Dive into the intricacies of ART in our latest blog post that analyzes the benefits, risks, and emerging data that’s shaping the conversation. Are we witnessing a transformative shift in care? Read our blog, which features insights from physicist Alex Price, PhD, and radiation oncologists Michael Chuong, MD, FACRO, and Percy Lee, MD, FASTRO. https://bit.ly/3SB2uVT JAMA Oncology, National Center for Biotechnology Information (NCBI), Washington University in St. Louis, Frontiers, American Society of Clinical Oncology (ASCO) #radiationoncology #cancercare #medicalphysics

𝗢𝗡𝗟𝗬 𝟯 𝗗𝗔𝗬𝗦 𝗧𝗢 𝗚𝗢 until our PSMA for prostate imaging webinar on 19th September at 6:30pm! Join our expert speaker Gary Cook, Professor of Molecular Imaging at Kings College London, for an insightful webinar exploring the pivotal role of PSMA in the management of prostate cancer. Explore how PSMA is enhancing diagnostic accuracy and treatment strategies for prostate cancer. To register your place, go to: https://bit.ly/47iPV8t #AllianceMedical #DedicatedToDiagnostics #Oncology #Radiology #Prostate #PatientCare #Healthcare #Medical #Webinar

Fimlab Laboratories has selected Aiforia Technologies to provide breast and prostate cancer diagnostic solutions. Fimlab is Finland’s largest healthcare laboratory company, running over 16 million diagnostic tests per year. Jukka Tapaninen, CEO of Aiforia, commented on the recent news: “We are extremely excited to officially kickstart this cooperation. Fimlab is a true pioneer in Finland, adopting AI solutions to support diagnostics in pathology. It is an honor to be part of this progressive step in our home country." Find out more about Aiforia by visiting their showcase on Pathology News and follow the link below to read this article in full... https://lnkd.in/euuPXjps #digitalpathology #pathologynews